Literature DB >> 25189914

Successful treatment of Panton-Valentine leukocidin-expressing Staphylococcus aureus-associated pneumonia co-infected with influenza using extracorporeal membrane oxygenation.

Noritomo Fujisaki1, Azusa Takahashi2, Takahiro Arima2, Tomoya Mizushima2, Katsuki Ikeda2, Hiroyuki Kakuchi2, Atsunori Nakao3, Joji Kotani4, Koji Sakaida2.   

Abstract

BACKGROUND: Panton-Valentine leukocidin (PVL) is a cytotoxin that causes leukocyte destruction and lung necrosis. Managing respiratory failure and acute respiratory distress syndrome secondary to PVL-expressing Staphylococcus aureus pneumonia and its associated lung necrosis with mechanical ventilation is challenging. We report a patient with life-threatening PVL-expressing S. aureus-associated pneumonia who was rescued using extracorporeal membrane oxygenation (ECMO). CASE REPORT: We examined the case of a woman who presented to our Emergency Department with septic shock due to PVL-expressing S. aureus-associated pneumonia. A 27-year-old Filipino woman was transferred to our hospital due to severe dyspnea, hemosputum, and high-grade fever. She had a medical history of osteosarcoma of the leg and hyperthyroidism. On arrival, her vital signs indicated septic shock, with a white blood cell count of 3.5×10(3)/μl. Because a Gram stain of her sputum indicated SA, therapy with antibiotics, including meropenem and vancomycin, was started. Hypoxemia necessitated intubation and ventilation. Because the patient's PaO2/FiO2 remained less than 60 mmHg and her blood pressure was unstable despite aggressive conventional management, venoarterial ECMO was administered approximately 11 h after her arrival. The ECMO circuit was changed to veno-venous ECMO on day 7 and the patient was successfully weaned off ECMO after 12 days of treatment. She was discharged from the hospital 104 days after admission.
CONCLUSION: This case demonstrates that early induction of ECMO support can be a reasonable therapeutic option for PVL-S. aureus-associated pneumonia. This patient's successful outcome might be attributable to early establishment of ECMO to prevent ventilation-induced lung injury.
Copyright © 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  PVL; Panton-Valentine leukocidin; Staphylococcus aureus; influenza; leukocyte destruction; lung necrosis; membrane oxygenation; pneumonia

Mesh:

Substances:

Year:  2014        PMID: 25189914

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  2 in total

1.  Combination of ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS due to Panton-Valentine leukocidin-positive Staphylococcus aureus pneumonia and H1N1.

Authors:  N J Lees; Ajp Rosenberg; A I Hurtado-Doce; J Jones; N Marczin; M Zeriouh; A Weymann; A Sabashnikov; A R Simon; A F Popov
Journal:  J Artif Organs       Date:  2016-07-19       Impact factor: 1.731

Review 2.  A review of sepsis-induced cardiomyopathy.

Authors:  Ryota Sato; Michitaka Nasu
Journal:  J Intensive Care       Date:  2015-11-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.